Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationNew Post-Market Surveillance (PMS) regulations have taken effect across Great Britain, requiring medical device manufacturers to proactively monitor the safety and performance of their products once on the market.
The newsletter for patients, consumers and healthcare professionals
Millions will take part in clinical trials under the 10 Year Health Plan which will speed up clinical research.
Comments Published
The RQA GPvP Committee have collated relevant pharmacovigilance news and will share quarterly.
Updated and published guidance on decentralised manufacture released.
Information to help you understand and prepare for the main regulatory changes that The Human Medicines (Amendment) Modular Manufacture and Point of Care regulations 2025 will introduce for the manufacture of medicines at - or close to - the point of patient care.
Documentation changed to support changes to Manufacturer Incident Reports (MIRs) and Field Safety Corrective Action Reports (FSCAs)
A new digital hub in Leeds is being launched by the Medicines and Healthcare products Regulatory Agency (MHRA), marking a significant step in the agency’s long-term commitment to advancing innovation and strengthening its presence across the UK.
22nd May 2025 Webinar added to page